ARTICLE | Company News
BioArctic, Biotecnol deal
March 9, 2015 7:00 AM UTC
The companies will use Biotecnol’s Tribody technology and BioArctic’s anti-amyloid beta antibodies to develop an in vivo diagnostic tool for Alzheimer’s disease (AD). The research will be conducted at...